Fig. 2From: Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study)Neoadjuvant treatment plans for the three arms. CRE: clinical response evaluationBack to article page